Here we demonstrate for the first time that the multispecificity, magnitude, and polyfunctional (type-1 and type-17) strength of CD8+ TEM cell responses directed to apoptotic self-epitopes were significantly higher in MS patients as compared with HDs. This evidence concerns the gene CD8A and myeloid sarcoma.